Re: early report imo
|
3
|
Resverlogix Corp.
|
Jul 03, 2022 01:41PM
|
Re: Pfizer
|
3
|
Zenith Epigenetics
|
Mar 12, 2024 08:12AM
|
Re: Amarin 3 or 5 point MACE
|
3
|
Resverlogix Corp.
|
Feb 13, 2019 10:02AM
|
Re: Lu stepping down
|
3
|
Resverlogix Corp.
|
Feb 21, 2024 07:53PM
|
Re: I followed up with Chris ..
|
3
|
Resverlogix Corp.
|
Nov 09, 2022 01:28PM
|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
3
|
BIOASIS TECHNOLOGIES INC
|
Nov 21, 2018 10:09AM
|
Re: Are statins overprescribed? Why the risks and benefits are so complex
|
3
|
Resverlogix Corp.
|
Dec 04, 2018 01:02PM
|
Re: Trading
|
3
|
Resverlogix Corp.
|
Aug 26, 2024 11:09AM
|
Re: What's the deal?
|
3
|
Resverlogix Corp.
|
Nov 28, 2020 05:59PM
|
Re: great,good,bad,ugly or so so??
|
3
|
Resverlogix Corp.
|
May 18, 2022 01:20PM
|
Re: New Covid mutation on the radar -- 'Mu'
|
3
|
Resverlogix Corp.
|
Sep 01, 2021 12:40PM
|
Re: Something "Material" is happening
|
3
|
Resverlogix Corp.
|
Mar 15, 2021 09:37PM
|
Re: Doing up another Seeking Alpha Post....maybe Wednesday
|
3
|
Resverlogix Corp.
|
Mar 24, 2019 05:23PM
|
Re: Book closes.....
|
3
|
Resverlogix Corp.
|
Jun 04, 2019 04:50PM
|
AZ- Another one bites the dust!
|
3
|
Resverlogix Corp.
|
Sep 09, 2019 03:01PM
|
Re: Book closes.....
|
3
|
Resverlogix Corp.
|
Jun 04, 2019 05:07PM
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
3
|
Resverlogix Corp.
|
May 09, 2022 05:09PM
|
Re: Article
|
3
|
Resverlogix Corp.
|
May 30, 2022 09:52AM
|
Re: Local TV Station Global Calgary
|
3
|
Resverlogix Corp.
|
Mar 12, 2021 11:08AM
|
Re: Not on the board, nor bored, but on board
|
3
|
Resverlogix Corp.
|
May 24, 2019 09:18AM
|